Radiation Oncology Institute launched with $5 million ASTRO grant

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 9
Volume 17
Issue 9

FAIRFAX, Virginia-The American Society for Therapeutic Radiology and Oncology (ASTRO) has invested $5 million in the newly created Radiation Oncology Institute (ROI). The goal of ROI is to support research and education in radiation therapy.

FAIRFAX, Virginia-The American Society for Therapeutic Radiology and Oncology (ASTRO) has invested $5 million in the newly created Radiation Oncology Institute (ROI). The goal of ROI is to support research and education in radiation therapy.

 

Theodore S. Lawrence, MD, PhD, from the University of Michigan in Ann Arbor and Colleen A. Lawton, MD, from the Medical College of Wisconsin in Milwaukee will lead the endowment campaign. Their goal is to raise $10 million in capital to build the infrastructure of the new ROI, according to ASTRO.

 

Once ROI is functional, it will serve as the chief philanthropic partner to ASTRO. Possible ROI programs include supporting research studies or impact analyses of new and existing treatment options; conducting outcomes studies on the efficacy and cost/ benefit of radiation therapy; and publishing radiation oncology-related trend data. ROI also will build a database of workforce and practice structures.

 

From ASTRO’s $5 million investment, $1 million will be used for an endowment and $1 million for initial seed funding.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts in this video
2 experts in this video
Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.
Increasing the use of patient-reported outcomes may ensure that practitioners can fully ascertain the impact of treatment for rare lymphomas.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
2 experts are featured in this series.
Related Content